Related Experiment Video
Updated: Jun 3, 2026
09:25
Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Toll-like receptor expression in smokers with and without COPD
Ida von Scheele1, Kjell Larsson, Barbro Dahlén
1The National Institute of Environmental Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden. Ida.von.Scheele@ki.se
Respiratory Medicine
|March 29, 2011
Summary
Pattern-recognition receptors (PRRs) like Toll-like receptor 2 (TLR2) and CD14 show altered expression in the lungs of smokers with chronic obstructive pulmonary disease (COPD). These changes in immune defense molecules may contribute to COPD development and exacerbations.
Area of Science:
- Immunology
- Pulmonology
- Respiratory Medicine
Background:
- Chronic obstructive pulmonary disease (COPD) involves airflow limitation and systemic inflammation.
- Bacterial lung colonization is frequent in COPD patients, potentially leading to acute exacerbations.
- Pattern-recognition receptors (PRRs), including Toll-like receptor 2 (TLR2), TLR4, and CD14, are crucial for immune responses and implicated in COPD pathophysiology.
Purpose of the Study:
- To investigate the expression of TLR2, TLR4, and CD14 in smokers with and without COPD.
- To compare PRR expression in different lung compartments and cell types between study groups.
Main Methods:
- Study included 20 smokers with COPD, 20 smokers without COPD, and 20 healthy non-smokers.
- Induced sputum, blood samples, and bronchoalveolar lavage were collected.
- Expression of TLR2, TLR4, and CD14 on various cell types and soluble forms were analyzed.
Main Results:
- TLR2 expression was decreased on sputum neutrophils, and soluble TLR2 (sTLR2) was increased in COPD patients.
- CD14 expression was upregulated on sputum neutrophils and alveolar macrophages in both smoking groups compared to non-smokers.
- No significant differences in TLR4 expression were observed across the groups.
Conclusions:
- PRRs, essential for initial microbial defense, exhibit altered regulation in smokers with COPD.
- These immune dysregulations are likely significant in COPD pathogenesis, particularly concerning microbially-driven exacerbations.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...